KALETRA
KALETRA
Approved
DIN Number
02243644
Drug Class
Human
Market Date
Mar 9, 2001
Company
HC
Abbvie Corporation
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02243644
AIG Number0243421002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J05AR10 LOPINAVIR AND RITONAVIR
Product Specifications
Dosage FormSolution
Route of AdministrationOral
AHFS Classification08:18.08.08
Health Canada Classification
ACTIVE INGREDIENTS (2)
LOPINAVIRActive
Strength: 400 MG / 5 ML
Monograph: LOPINAVIR
RITONAVIRActive
Strength: 100 MG / 5 ML
Monograph: RITONAVIR